Venthera

Manufacturing · Massachusetts, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

75 Park Plz Ste 2, Boston, Massachusetts...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About Venthera

Venthera, an affiliate of BridgeBio Pharma, is a biotechnology company focused on developing therapeutics for the treatment of venous and lymphatic malformations, congenital conditions that are driven by activating mutations of the PI3K signaling pathway. We aim to develop a safe and effective treatment for these painful disorders as quickly and safely as possible.Explore more
Venthera's Social MediaPopular SearchesVentheraVenthera IncSIC Code 28,283NAICS Code 32,325Show more

Is Venthera your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Venthera

Compare insights from companies similar to Venthera, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Venthera

<$5M
1-10
Private
-
2018
N/A
$5.1M
11-50
Public
$31.3M
2015
ML
Martin LehrCEO & Director
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
$5M
2019
SK
Sarath KanekalVice President, Regulatory Affairs
<$5M
1-10
Private
<$5M
2018
RR
Randall RiggsPresident & CEO
<$5M
1-10
Private
$18.1M
2014
<$5M
1-10
Private
<$5M
2005
AR
Armin ReitmairVice President, Translational Research Consulting
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Venthera is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Venthera is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Venthera.

Venthera Tech Stack

A closer look at the technologies used by Venthera

Venthera News & Media

Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Venthera

What is Venthera's official website?
Venthera's official website is www.venthera.com
What is Venthera's Revenue?
Venthera's revenue is <$5 Million
What is Venthera's SIC code?
Venthera's SIC: 28,283
What is Venthera's NAICS code?
Venthera's NAICS: 32,325
How many employees does Venthera have?
Venthera has 1-10 employees
What industry does Venthera belong to?
Venthera is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Venthera competition?
Venthera top competitors include: Navire, Iterion Therapeutics, Gibson Oncology, Context Therapeutics
What technology does Venthera use?
Some of the popular technologies that Venthera uses are: DocuSign, Proofpoint, Microsoft 365, GoDaddy DNS
What does Venthera do?

Venthera, an affiliate of BridgeBio Pharma, is a biotechnology company focused on developing therapeutics for the treatment of venous and lymphatic malformations, congenital conditions that are driven by activating mutations of the PI3K signaling pathway. We aim to develop a safe and effective treatment for these painful disorders as quickly and sa... fely as possible.Read More

What are Venthera social media links?
Venthera Linkedin page
Is Venthera a public company?
Venthera is private company therefore does not currently have an official ticker symbol
See more information about Venthera

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.